Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).
Chen IM, Donia M, Chamberlain CA, Jensen AWP, Draghi A, Theile S, Madsen K, Hasselby JP, Toxværd A, Høgdall E, Lorentzen T, Wilken EE, Geertsen P, Svane IM, Johansen JS, Nielsen D. Chen IM, et al. Among authors: jensen awp. Eur J Cancer. 2023 Feb;180:125-133. doi: 10.1016/j.ejca.2022.11.035. Epub 2022 Dec 10. Eur J Cancer. 2023. PMID: 36592507 Free article. Clinical Trial.
Proteomics to study cancer immunity and improve treatment.
Franciosa G, Kverneland AH, Jensen AWP, Donia M, Olsen JV. Franciosa G, et al. Among authors: jensen awp. Semin Immunopathol. 2023 Mar;45(2):241-251. doi: 10.1007/s00281-022-00980-2. Epub 2023 Jan 4. Semin Immunopathol. 2023. PMID: 36598558 Free PMC article. Review.
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma.
Draghi A, Presti M, Jensen AWP, Chamberlain CA, Albieri B, Rasmussen AK, Andersen MH, Crowther MD, Svane IM, Donia M. Draghi A, et al. Among authors: jensen awp. Clin Cancer Res. 2023 Oct 2;29(19):3937-3947. doi: 10.1158/1078-0432.CCR-22-3853. Clin Cancer Res. 2023. PMID: 37126006
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
Tvingsholm SA, Frej MS, Rafa VM, Hansen UK, Ormhøj M, Tyron A, Jensen AWP, Kadivar M, Bentzen AK, Munk KK, Aasbjerg GN, Ternander JSH, Heeke C, Tamhane T, Schmess C, Funt SA, Kjeldsen JW, Kverneland AH, Met Ö, Draghi A, Jakobsen SN, Donia M, Marie Svane I, Hadrup SR. Tvingsholm SA, et al. Among authors: jensen awp. J Immunother Cancer. 2023 Aug;11(8):e006847. doi: 10.1136/jitc-2023-006847. J Immunother Cancer. 2023. PMID: 37586765 Free PMC article.
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy.
Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Nielsen M, et al. Among authors: jensen awp. Cancer Immunol Res. 2022 Oct 4;10(10):1254-1262. doi: 10.1158/2326-6066.CIR-22-0326. Cancer Immunol Res. 2022. PMID: 35969233
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
Jensen AWP, Carnaz Simões AM, Thor Straten P, Holmen Olofsson G. Jensen AWP, et al. Cancers (Basel). 2021 Jan 21;13(3):394. doi: 10.3390/cancers13030394. Cancers (Basel). 2021. PMID: 33494360 Free PMC article. Review.
Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo.
Holmen Olofsson G, Jensen AWP, Idorn M, Thor Straten P. Holmen Olofsson G, et al. Among authors: jensen awp. Int J Mol Sci. 2020 May 27;21(11):3816. doi: 10.3390/ijms21113816. Int J Mol Sci. 2020. PMID: 32471301 Free PMC article. Review.